“We have to get this message out,” Jacobson said. “We have started to be contacted by people. But … clinical partners and funding agencies who will hopefully su

“We have to get this message out,” Jacobson said. “We have started to be contacted by people. But … clinical partners and funding agencies who will hopefully support this work is the next step that needs to happen.” Yes! Clinical trials are required to isolate bradykinin dysregulation as a primary cause of COVID-19 morbidity. If that happens, the good news is that drug therapies already exist, which means the death toll from the virus could be cut dramatically in a short time. It's bizarre that the chief scientist for computational systems biology at a prestigious government research facility such as Oak Ridge National Labs doesn't already have connections to facilitate clinical trials in advance. This is the true cost of the crony capitalism that has seen sham treatments such as hydroxychloroquine dominate clinical opportunities and administrative bandwidth of the pandemic response.